Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.72
1.32%
After-hours: Aug 15, 2025, 07:28 PM EDT

Tempest Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.27M 39.23M 31.23M 51.83M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
388K n/a n/a n/a
Other Long-Term Assets
97K 448K 429K 111K
Receivables
n/a n/a 450K 15M
Inventory
n/a n/a n/a n/a
Other Current Assets
535K 96K 263K 553K
Total Current Assets
31.47M 40.36M 32.95M 68.96M
Property-Plant & Equipment
9.53M 10.79M 12.71M 4.16M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
10.01M 11.24M 13.14M 4.28M
Total Assets
41.49M 51.6M 46.09M 73.24M
Account Payables
2.45M 845K 1.11M 991K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
6.35M 4.29M n/a n/a
Other Current Liabilities
n/a 1.79M 2.1M 13.56M
Total Current Liabilities
14.22M 9.41M 7.28M 20.03M
Long-Term Debt
n/a 6.26M 10.37M 15.07M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
8.14M 15.42M 20.7M 17.09M
Total Liabilities
22.36M 24.84M 27.98M 37.12M
Total Debt
15.37M 20.66M 22.11M 18.54M
Common Stock
44K 22K 11K 7K
Retained Earnings
-207.11M -165.26M -135.77M -100.06M
Comprehensive Income
n/a n/a n/a -73.24M
Shareholders Equity
19.13M 26.77M 18.11M 36.12M
Total Investments
388K 388K n/a n/a